Salazopyrin EN Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Sulfasalazine

Indications/Uses

Mild to moderate ulcerative colitis & adjunct therapy in severe ulcerative colitis; maintenance of remission in ulcerative colitis. Active Crohn's disease especially in patients w/ colonic involvement. RA.

Dosage/Direction for Use

Inflammatory bowel diseases Adult Severe attacks: 2-4 tab tds-qds in conjunction w/ steroids. Mild & moderate attacks: 2 tab tds-qds. Childn 40-60 mg/kg daily in 3-6 divided doses. Prophylaxis against relapses Adult 2 tab bd-tds. Childn 20-30 mg/kg daily in 3-6 divided doses. RA Adult 2 tab bd. Start therapy by 1 tab in the evening for 1st wk, 1 tab in the morning & evening for 2nd wk, 1 tab in the morning & 2 tab in the evening for 3rd wk, 2 tab in the morning & evening for 4th wk & after. May increase dose to 3 g daily if no response has been seen after 2 mth.

Administration

Should be taken with food: Take preferably after meals. Swallow whole, do not crush/break.

Contraindications

Hypersensitivity to sulfasalazine, its metabolites, or to sulfonamides & salicylates. Porphyria.

MIMS Class

GIT Regulators, Antiflatulents & Anti-Inflammatories / Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

A07EC01 - sulfasalazine ; Belongs to the class of aminosalicylic acid and similar antiinflammatory. Used in the treatment of intestinal inflammation.

Regulatory Classification

POM

Presentation/Packing

Form

Salazopyrin EN EC tab 500 mg

Packing/Price

1's

Salazopyrin EN

sulfasalazine

Manufacturer:

Recipharm